KR102272849B1 - 복합 시스템에 대한 입력 파라미터들의 최적화된 조합들의 빠른 식별 - Google Patents

복합 시스템에 대한 입력 파라미터들의 최적화된 조합들의 빠른 식별 Download PDF

Info

Publication number
KR102272849B1
KR102272849B1 KR1020157021024A KR20157021024A KR102272849B1 KR 102272849 B1 KR102272849 B1 KR 102272849B1 KR 1020157021024 A KR1020157021024 A KR 1020157021024A KR 20157021024 A KR20157021024 A KR 20157021024A KR 102272849 B1 KR102272849 B1 KR 102272849B1
Authority
KR
South Korea
Prior art keywords
drug
agent
tests
input parameters
delete delete
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
KR1020157021024A
Other languages
English (en)
Korean (ko)
Other versions
KR20150110567A (ko
Inventor
치흐-밍 호
시안팅 딩
이엉 웡
Original Assignee
더 리전트 오브 더 유니버시티 오브 캘리포니아
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 더 리전트 오브 더 유니버시티 오브 캘리포니아 filed Critical 더 리전트 오브 더 유니버시티 오브 캘리포니아
Publication of KR20150110567A publication Critical patent/KR20150110567A/ko
Application granted granted Critical
Publication of KR102272849B1 publication Critical patent/KR102272849B1/ko
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16C—COMPUTATIONAL CHEMISTRY; CHEMOINFORMATICS; COMPUTATIONAL MATERIALS SCIENCE
    • G16C20/00—Chemoinformatics, i.e. ICT specially adapted for the handling of physicochemical or structural data of chemical particles, elements, compounds or mixtures
    • G16C20/70—Machine learning, data mining or chemometrics
    • G—PHYSICS
    • G06—COMPUTING OR CALCULATING; COUNTING
    • G06F—ELECTRIC DIGITAL DATA PROCESSING
    • G06F17/00—Digital computing or data processing equipment or methods, specially adapted for specific functions
    • G06F17/10—Complex mathematical operations
    • G06F17/11—Complex mathematical operations for solving equations, e.g. nonlinear equations, general mathematical optimization problems
    • G—PHYSICS
    • G06—COMPUTING OR CALCULATING; COUNTING
    • G06F—ELECTRIC DIGITAL DATA PROCESSING
    • G06F30/00—Computer-aided design [CAD]
    • G06F30/20—Design optimisation, verification or simulation
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16C—COMPUTATIONAL CHEMISTRY; CHEMOINFORMATICS; COMPUTATIONAL MATERIALS SCIENCE
    • G16C99/00—Subject matter not provided for in other groups of this subclass
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/50—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for simulation or modelling of medical disorders
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H70/00—ICT specially adapted for the handling or processing of medical references
    • G16H70/40—ICT specially adapted for the handling or processing of medical references relating to drugs, e.g. their side effects or intended usage
    • G—PHYSICS
    • G06—COMPUTING OR CALCULATING; COUNTING
    • G06F—ELECTRIC DIGITAL DATA PROCESSING
    • G06F2119/00—Details relating to the type or aim of the analysis or the optimisation
    • G06F2119/22—Yield analysis or yield optimisation
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B5/00—ICT specially adapted for modelling or simulations in systems biology, e.g. gene-regulatory networks, protein interaction networks or metabolic networks
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
    • G16H10/20—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for electronic clinical trials or questionnaires
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients

Landscapes

  • Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Theoretical Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Data Mining & Analysis (AREA)
  • General Physics & Mathematics (AREA)
  • Medical Informatics (AREA)
  • Mathematical Physics (AREA)
  • Databases & Information Systems (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pure & Applied Mathematics (AREA)
  • Computational Mathematics (AREA)
  • Mathematical Optimization (AREA)
  • Mathematical Analysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Software Systems (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Evolutionary Computation (AREA)
  • Epidemiology (AREA)
  • Primary Health Care (AREA)
  • Operations Research (AREA)
  • Algebra (AREA)
  • Computing Systems (AREA)
  • Pathology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Computer Vision & Pattern Recognition (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Artificial Intelligence (AREA)
  • Evolutionary Biology (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Physiology (AREA)
  • Biotechnology (AREA)
  • Computer Hardware Design (AREA)
  • Geometry (AREA)
KR1020157021024A 2013-01-17 2014-01-17 복합 시스템에 대한 입력 파라미터들의 최적화된 조합들의 빠른 식별 Active KR102272849B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361753842P 2013-01-17 2013-01-17
US61/753,842 2013-01-17
PCT/US2014/012111 WO2014113714A1 (en) 2013-01-17 2014-01-17 Rapid identification of optimized combinations of input parameters for a complex system

Publications (2)

Publication Number Publication Date
KR20150110567A KR20150110567A (ko) 2015-10-02
KR102272849B1 true KR102272849B1 (ko) 2021-07-02

Family

ID=51210107

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020157021024A Active KR102272849B1 (ko) 2013-01-17 2014-01-17 복합 시스템에 대한 입력 파라미터들의 최적화된 조합들의 빠른 식별

Country Status (9)

Country Link
US (2) US20150356269A1 (cg-RX-API-DMAC7.html)
EP (1) EP2946263A4 (cg-RX-API-DMAC7.html)
JP (3) JP2016507105A (cg-RX-API-DMAC7.html)
KR (1) KR102272849B1 (cg-RX-API-DMAC7.html)
CN (1) CN104981752A (cg-RX-API-DMAC7.html)
AU (2) AU2014207327A1 (cg-RX-API-DMAC7.html)
CA (1) CA2898324A1 (cg-RX-API-DMAC7.html)
SG (1) SG11201505579TA (cg-RX-API-DMAC7.html)
WO (1) WO2014113714A1 (cg-RX-API-DMAC7.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3020221C (en) * 2016-04-13 2024-04-16 Skillcell Method for the preparation of biosynthetic device and their uses in diagnostics
WO2021014343A1 (en) * 2019-07-23 2021-01-28 Reagene Innovations Pvt. Ltd. Artificial intelligence guided identification of affordable re-purposed drugs for leukemias
US20220367023A1 (en) * 2019-10-18 2022-11-17 National University Of Singapore Method for Predicting a Suitable Therapy

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040107084A1 (en) 2002-09-16 2004-06-03 Optimata Interactive technique for optimizing drug development from the pre-clinical phases through phase-IV
US20040138826A1 (en) 2002-09-06 2004-07-15 Carter Walter Hansbrough Experimental design and data analytical methods for detecting and characterizing interactions and interaction thresholds on fixed ratio rays of polychemical mixtures and subsets thereof
JP2010524055A (ja) * 2007-03-30 2010-07-15 9898リミテッド 天然物開発のための薬剤プラットフォーム技術
KR101013940B1 (ko) 2009-11-12 2011-02-14 주식회사 자연인 방풍통성산 한약재로부터 방향성 물질을 추출하는 방법

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4368509A (en) * 1979-08-24 1983-01-11 Li Chou H Self-optimizing machine and method
JPH11154170A (ja) * 1997-11-20 1999-06-08 Oki Electric Ind Co Ltd 回路シミュレータ
US7124031B1 (en) * 2000-05-11 2006-10-17 Medco Health Solutions, Inc. System for monitoring regulation of pharmaceuticals from data structure of medical and labortory records
US20020165762A1 (en) * 2001-05-02 2002-11-07 Clinical Discovery Israel Ltd. Method for integrated analysis of safety, efficacy and business aspects of drugs undergoing development
US20040009536A1 (en) * 2001-07-30 2004-01-15 George Grass System and method for predicting adme/tox characteristics of a compound
JP3987059B2 (ja) * 2004-07-30 2007-10-03 株式会社東芝 最適値探索支援装置、最適値探索支援方法、及び記録媒体
JP2007041784A (ja) * 2005-08-02 2007-02-15 Toshiba Corp 最適値探索支援装置、最適値探索支援方法、及びプログラム
JP4670826B2 (ja) * 2007-03-26 2011-04-13 トヨタ自動車株式会社 制御パラメータの実験計画設定方法、その実験計画設定方法をコンピュータに実行させるためのプログラム、およびそのプログラムを記録したコンピュータ読取可能な記録媒体
SG177937A1 (en) * 2008-03-26 2012-02-28 Theranos Inc Methods and systems for assessing clinical outcomes
US20130041683A1 (en) * 2010-04-07 2013-02-14 Novacare Computer based system for predicting treatment outcomes
US20120078521A1 (en) * 2010-09-27 2012-03-29 General Electric Company Apparatus, system and methods for assessing drug efficacy using holistic analysis and visualization of pharmacological data

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040138826A1 (en) 2002-09-06 2004-07-15 Carter Walter Hansbrough Experimental design and data analytical methods for detecting and characterizing interactions and interaction thresholds on fixed ratio rays of polychemical mixtures and subsets thereof
US20040107084A1 (en) 2002-09-16 2004-06-03 Optimata Interactive technique for optimizing drug development from the pre-clinical phases through phase-IV
JP2010524055A (ja) * 2007-03-30 2010-07-15 9898リミテッド 天然物開発のための薬剤プラットフォーム技術
KR101013940B1 (ko) 2009-11-12 2011-02-14 주식회사 자연인 방풍통성산 한약재로부터 방향성 물질을 추출하는 방법

Also Published As

Publication number Publication date
EP2946263A4 (en) 2016-08-31
WO2014113714A1 (en) 2014-07-24
US20150356269A1 (en) 2015-12-10
JP2022048275A (ja) 2022-03-25
US20210358636A1 (en) 2021-11-18
CA2898324A1 (en) 2014-07-24
JP2019029027A (ja) 2019-02-21
CN104981752A (zh) 2015-10-14
SG11201505579TA (en) 2015-08-28
JP2016507105A (ja) 2016-03-07
KR20150110567A (ko) 2015-10-02
EP2946263A1 (en) 2015-11-25
AU2014207327A1 (en) 2015-08-06
AU2019257388A1 (en) 2019-11-14

Similar Documents

Publication Publication Date Title
Siddique et al. FLASH radiotherapy and the use of radiation dosimeters
Cuzzolin et al. DockBench: an integrated informatic platform bridging the gap between the robust validation of docking protocols and virtual screening simulations
US20210358636A1 (en) Rapid identification of optimized combinations of input parameters for a complex system
Hartung Efficient resolution of metastatic tumour growth models by reformulation into integral equations
KR102344774B1 (ko) 자극을 동적으로 변화시키는 실-시간 피드백 시스템 제어 기술 플랫폼
Smieja Mathematical modeling support for lung cancer therapy—A short review
Kanapka et al. A frequentist design for basket trials using adaptive lasso
Dygai et al. Comparison of specific activity of granulocytopoiesis stimulators after treatment with cytostatics with different mechanisms of action
Siranart et al. Mixed beam murine harderian gland tumorigenesis: predicted dose-effect relationships if neither synergism nor antagonism occurs
Bunimovich-Mendrazitsky et al. Optimization of combined leukemia therapy by finite-dimensional optimal control modeling
Mazzaglia et al. Absorbed dose evaluation in radioiodine therapy with different approaches
Tantaoui et al. Impact of pseudo-random number generators on dosimetric parameters in validation of medical linear accelerator head simulation for 6 MV photons using the GATE/GEANT4 platform
Nikitin et al. Improved data processing algorithm for laser ektacytometry of red blood cells
Costes WEBINAR, May 6: New Discoveries Using GeneLab
Cornes et al. Commentary-A comprehensive safety understanding of granulocyte-colony stimulating factor biosimilars and Intended Copy Biologics in treating chemotherapy associated febrile neutropenia
Cardilin Modeling of combination therapy to support drug discovery in oncology
Novick et al. Drug combination design strategies
Keutzer Model-informed tuberculosis drug development and treatment optimization
Lin Advance in physiologically based pharmacokinetic modelling: from the organ level to suborgan level based on experimental data
Rodríguez et al. Linking Drug or Phytochemical Exposure to Toxicity
Soule Legends in Urology
Katiyar et al. A Bayesian Approach to Determine the Composition of Heterogeneous Cancer Tissue
Qiu QSAR modeling of chemical penetration enhancers using novel replacement algorithms
Ravi Berwal et al. A review on process of drug discovery and development.
Harder et al. Wolfgang Pohlit (1928–2005)

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

R17-X000 Change to representative recorded

St.27 status event code: A-3-3-R10-R17-oth-X000

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

P22-X000 Classification modified

St.27 status event code: A-2-2-P10-P22-nap-X000

P22-X000 Classification modified

St.27 status event code: A-2-2-P10-P22-nap-X000

P22-X000 Classification modified

St.27 status event code: A-2-2-P10-P22-nap-X000

P22-X000 Classification modified

St.27 status event code: A-2-2-P10-P22-nap-X000

A201 Request for examination
PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

P22-X000 Classification modified

St.27 status event code: A-2-2-P10-P22-nap-X000

P22-X000 Classification modified

St.27 status event code: A-2-2-P10-P22-nap-X000

D13-X000 Search requested

St.27 status event code: A-1-2-D10-D13-srh-X000

D14-X000 Search report completed

St.27 status event code: A-1-2-D10-D14-srh-X000

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U12-oth-PR1002

Fee payment year number: 1

PG1601 Publication of registration

St.27 status event code: A-4-4-Q10-Q13-nap-PG1601

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 4

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 5

U11 Full renewal or maintenance fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U11-OTH-PR1001 (AS PROVIDED BY THE NATIONAL OFFICE)

Year of fee payment: 5